Nanobiotix Files March 2025 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Nanobiotix filed its monthly 6-K, just a routine update, no big news.
AI Summary
Nanobiotix S.A. filed a Form 6-K on March 20, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Nanobiotix is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material information that would inherently increase risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- Paris, France (location) — Company Headquarters
- March 2025 (date) — Reporting Period
- 20250320 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information which the issuer has made or is required to make public pursuant to the laws of its home country or jurisdiction, or a stock exchange on which its securities are traded, or that it has submitted or will submit to its security holders.
What is Nanobiotix S.A.'s standard annual reporting form?
Nanobiotix S.A. files its annual reports under cover of Form 20-F.
Where is Nanobiotix S.A. headquartered?
Nanobiotix S.A. is headquartered at 60 Rue de Wattignies, 75012 Paris, France.
What is the SEC file number for Nanobiotix S.A.?
The SEC file number for Nanobiotix S.A. is 001-39777.
Does this 6-K filing contain specific financial results for March 2025?
No, this Form 6-K filing for March 2025 does not appear to contain specific financial results or operational updates beyond its status as a routine report.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding Nanobiotix S.A. (NBTX).